27th Annual Meeting of the European Charcot Foundation, 21 - 23 November 2019, Baveno
 
Dr Martina Absinta
NIH
Dr. Francesca Aloisi
Istituto Superore di Sanita
Prof. Amit Bar-Or
Prof. Luca Battistini
Prof. Jeffrey Bennett
Dr Joakim Bergman
Prof. Alexey Boyko
Russian State Medical University, Neuroclinica, MS Center
Prof. Massimiliano Calabrese
Prof. William Carroll
Perron Institute Perth
Prof. Jeffrey Cohen
Cleveland Clinic Lerner College of Medicine
Prof. Manuel Comabella Lopez
Prof. Giancarlo Comi
San Raffaele Scientific Institute


Giancarlo Comi is Professor of Neurology, Chairman of the Department of Neurology, and Director of the Institute of Experimental Neurology at Vita-Salute San Raffaele University, Milan, Italy. He is also President of the European Charcot Foundation (ECF), a member of the Board of Administration of the Italian Multiple Sclerosis Foundation and of the Scientific Committee of Associazione Italiana Sclerosi Multipla, Co-Chair of the Scientific Steering Committee of the Progressive MS Alliance, and a fellow of the European Academy of Neurology (EAN). He has served as a past president of the European Neurology Society, the Italian Society of Clinical Neurophysiology, and the Italian Society of Neurology.

In recent years, Professor Comi has received the ‘Gh. Marinescu’ honorary award from the Romanian Society of Neurology, and has been awarded honorary memberships of the Russian Neurological Academic Society, the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), the European Neurological Society (ENS) and the Sociedad Espanola de Neurologia. He also received the Charcot Award for MS Research from the MS International Federation (MSIF) in 2015. In the past year Professor Comi was awarded the Gold Medal of ‘Benemeranza Civica’ from the City of Milan and has been recently conferred the honor of merit as Official by the President of Italy.

Prof. Comi has authored and co-authored more than 1000 articles in peer-reviewed journals, and edited several books, with an h-index of 100. He has been the invited speaker for more than 450 conferences, both nationally and internationally. He sits on the executive boards of various scientific associations and on the editorial boards of Clinical Investigation, European Journal of Neurology and Multiple Sclerosis. He is also the Associate Editor of the Neurological Sciences.


Prof. Jorge Correale
Prof. Edgardo Cristiano
Hospital Italiano de Buenos Aires
Dr Klaus Dornmair
Prof. Gilles Edan
CHU Rennes

Gilles Edan is currently professor of clinical neurology and chair of the Department of Neurosciences at the University Hospital of Rennes, France. After completing his MD at the University of Rennes in 1981, he went on to specialize in neurology under the supervision of Pr Olivier Sabouraud , was a research fellow at Guy’s hospital (London) in neuroimmunology with RAC Hughes in 1987, spent a sabbatical period of 6 months at the MS clinic of UBC with Don Paty and Joel Oger in Vancouver in 1996 and set up a MS clinic in Brittany in 1996. Gilles Edan was one of the members of the international panel for the new diagnostic criteria of MS (Mc Donald criteria) in 2001 and 2005. He published more than 200 peer-reviewed original papers on his MS researches in Journals and several chapters in books on these subjects.


Prof. Óscar Fernández
Instituto de Investigación Biomédica de Málaga (IBIMA) Hospital Regional Universitario de Málaga
Prof. Kazuo Fujihara
Fukushima Medical University

Kazuo Fujihara, M.D. is Professor, Department of Multiple Sclerosis Therapeutics, Fukushima Medical University School of Medicine, and Director, Multiple Sclerosis & Neuromyelitis Optica Center, Southern TOHOKU Research Institute for Neuroscience (STRINS), Koriyama 963-8563, Japan. Dr. Fujihara is a neurologist and has mainly worked in the field of multiple sclerosis (MS), neuromyelitis optica (NMO) and related neuroimmunological disorders. He contributed to the 2010 and 2016-2017 Revisions to McDonald Criteria in the International Panel on Diagnosis of MS, and is a member of the International Panel on NMO Diagnosis. He has also served on the Board of European Charcot Foundation (2013~), the Executive Committee, International Medical and Scientific Board of The Multiple Sclerosis International Federation (2013~) and an External Reviewer of Malaysian Clinical Practice Guidelines (CPG), Management of Multiple Sclerosis. He is an inaugural member and Deputy Secretary of PACTRIMS and a co-convener of “MS and Other Inflammatory Diseases” in the 23rd World Congress of Neurology (2017, Kyoto). He is a member of International Advisory Board of Sri Lankan Journal of Neurology (2012~), an Honorary Corresponding Member of the Indian Academy of Neurology (2015~), and an Honorary Fellow of the Hong Kong Multiple Sclerosis Society (2015~).


Dr Matteo Gastaldi
IRCCS Mondino Foundation
Dr Angelo Ghezzi
Centro Studi Sclerosi Multipla

Dr Angelo Ghezzi is chief emeritus of Neurology. He is the responsible of scientific research at Multiple Sclerosis Study Centre of St Antonio Abate Hospital in Gallarate, Italy, the oldest Italian MS center. He is member of the Steering Committee of the International Pediatric MS Study Group, and member of the Italian MS Study Group of the Italian Neurological Society Dr Ghezzi has been an active researcher, serving as an investigator in many international Phase II and III trials. His research has focused on the areas of optic neuritis, MS and pregnancy, MS and sexual disturbances, MS and epilepsy, MS evolution and prognosis, MRI and clinical correlation with MS, and clinical neurophysiology (evoked potentials, pelvic floor neurophysiology); however, he is especially interested in the clinical and therapeutic aspects of pediatric MS (MS onset in childhood-adolescence, immunomodulatory treatment of juvenile-onset MS). Dr Ghezzi is the editor of 10 books on multiple sclerosis, and author or co-author of more than 200 articles published in international journals.


Prof. Jennifer Gommerman
Prof. Hans-Peter Hartung
Heinrich-Heine-University

Professor Hartung received his undergraduate training at the Universities of Düsseldorf, Glasgow, Oxford and London. After graduation magna cum laude as MD in 1980 he served an immunology fellowship at JohannesGutenberg-University of Mainz. He started his career in neurology at the University of Düsseldorf, where he became assistant professor in 1987. He was appointed professor and head of the MS clinical research group and Vice Chair of the Department of Neurology at Julius-Maximilians-University of Würzburg in 1990 and moved in 1997 to Graz, Austria, to become chairman of the University Department of Neurology. He is currently chair of the Department of Neurology at Heinrich Heine University Düsseldorf, a position he has held since 2001, and since 2012 director of the Center for Neurology and Neuropsychiatry. He is also Medical Director of the Department of Conservative Medicine at Düsseldorf University Hospital.

Professor Hartung’s clinical and translational research interests are in the field of basic and clinical neuroimmunology and in particular multiple sclerosis and immune neuropathies, development of new immunological, neuroprotective and neural repair promoting strategies. He has authored or co-authored more than 900 articles in peer-reviewed journals, one hundred book chapters and edited nine books. He is a Highly Cited Researcher 2017 (Web of Science).

He was President of ECTRIMS and has served / serves amongst others on the executive boards of the European Charcot Foundation, the International Society of Neuroimmunology, Peripheral Nerve Society, INC,WHO Working Group on Multiple Sclerosis, GBS CIDP Foundation International, MSIF and the German MS Society and theUS NMS Society and ECTRIMS clinical trials committee. He is member of the executive board of IMSCOGS. He is/ was also member of the Editorial Board of a number of international journals.


Prof. Stephen Hauser
University of California San Francisco Medical Center
Dr Darius Häusler
Prof. Romana Höftberger
Prof. Reinhard Hohlfeld
Institute of Clinical Neuroimmunology, Klinikum der LMU München, Campus Grosshadern
Prof. Ludwig Kappos
University Hospital Basel

Grown up in Athens, Greece Ludwig Kappos obtained his M.D. and a Diploma in Clinical Psychology from the University of Würzburg, Germany, in 1980, where he went on to specialise in Neurology and Neuroimmunology, and became Deputy Chief, Division of Clinical Neurology, Max Planck Society, Clinical Research Unit for Multiple Sclerosis. In 1990 he was elected Head of the Outpatient Department, Neurology/Neurosurgery and since 2008 Chair of Neurology at the University of Basel, Switzerland. Research interests include immuno-logical and molecular studies in neuroimmunological diseases, methodology and conduct of therapeutic studies mainly in the field of MS, standardisation of clinical assessment, development of biomarkers and use of magnetic resonance tomography in elucidating the pathogenesis of inflammatory CNS disease and as tool in monitoring therapeutic studies. Ludwig Kappos serves as chair or member in several steering committees and advisory boards of Clinical Trials and Organizations active in the field of MS and general Neurology. Ludwig Kappos has published more than 750 original papers, reviews and book chapters. He has been awarded with several prizes and honorary doctorates for his scientific contributions.


Prof. Luisa Klotz


Professor Luisa Klotz studied medicine at the University of Bonn (Germany), graduating in 2002. She has been a research fellow at the Institute of Molecular Medicine and Experimental Immunology, University of Bonn, where she was a junior group leader within the BONFOR programme. Since 2011 she is an independent group leader for Immunemodulation and since 2013 head of the clinical trial unit ‘Neuroimmunology and IITs’ at the Department of Neurology, University Hospital Münster (Germany) and holds a Professorship for ‘Neurological Immune Therapy’ since 2016.

Her research focusses on immunemodulatory properties of nuclear receptors, innate and adaptive immune responses in CNS autoimmunity, spontaneous EAE models as well as pathologic immune responses in multiple sclerosis and novel therapeutic approaches.
Professor Klotz is CEO of the “Innovative Medical Research” funding organization, Faculty of Medicine, University Hospital Münster and is Co-PI of the Clinical Competence Network Multiple Sclerosis supported by the Federal Ministry of Research and Education (BMBF). Her achievements have been recognized by several awards, among them the Sobek award 2012 of the German Society for Multiple Sclerosis (DMSG).

 
 
Prof. Hans Lassmann
Medical University of Vienna
Prof. Letizia Leocani
San Raffaele Scientific Institute

Letizia Leocani is Associate Professor of Neurology at San Raffaele University and Supervisor of the Experimental Neurophysiology Unit and of Magnetic IntraCerebral Stimulation center. She had a PhD in Human Physiology and she has been Research Fellow at the Human Motor Control Section of the National Institutes of Health in Bethesda-USA. Her fields of interest involve translational validation of electrophysiological and OCT markers of neurological diseases and of treatment using non invasive brain stimulation.


Dr Roberta Magliozzi
Prof. Edgar Meinl
Dr Laure Michel
Prof. Tatsuro Misu
Prof. Lucia Moiola
Prof. Xavier Montalban
University of Toronto & CEMCAT

Dr. Montalban is the Director of the Division of Neurology at the University of Toronto and Director of the MS centre at St Michael’s Hospital in Toronto. Also, he currently Chairs the Department of Neurology-Neuroimmunology and is the director of the Multiple Sclerosis Centre of Catalonia at the Vall d’Hebron University Hospital in Barcelona. He is the former director of the Department of Neuroscience and Chief of the Neuroimmunology Research Group at the Vall d’Hebron Research Institute. Dr. Montalban received his medical license, trained as a Neurology specialist and completed his PhD in neuroimmunology during the 1980s at the Universitat Autònoma de Barcelona. He went on to undertake a postdoctoral fellowship at the Lupus Research Institute, Guy’s & St. Thomas’ Hospital plus additional clinical training at the National Hospital for Neurology and Neurosurgery, Queen Square in London, United Kingdom.

Dr. Montalban is Vice-President of Fundació Esclerosi Múltiple (MS Foundation), President of the Fundació Cemcat and former President of the Executive Committee of the European Committee for the Treatment and Research in Multiple Sclerosis (ECTRIMS). He is a member of the US National Multiple Sclerosis Society Clinical Trials Committee and he chairs the Medical & Scientific Board of the Multiple Sclerosis International Federation (MSIF). He is a member of the Board of the European Charcot Foundation.

In the past twenty years, Dr. Montalban has been in the inception phases and on steering committees of many clinical trials related to multiple sclerosis. He has authored over 600 original and revision publications in international peer-reviewed journals, as well as several book chapters. Recently, he co-directed the development of the first ECTRIMS-EAN Multiple Sclerosis Treatment Guidelines. He is the editor of the Clinical Cases Section of the Multiple Sclerosis Journal.

His research interests include clinical trials, clinical aspects of MS, MR imaging and biological prognostic factors of disease evolution and treatment response, immunological mechanisms of the disease and other aspects of clinical management of MS.


Dr Jacqueline Palace
John Radcliffe Hospital

Dr Jackie Palace is a consultant neurologist in Oxford and Associate Professor of Nuffield Department of Clinical Neurosciences, Oxford University. She leads the Oxford Multiple Sclerosis group and runs a national service for congenital myasthenic syndromes (CMS) and jointly a UK neuromyelitis optica service (NMO) which includes adults and children. Her MS service comprises a regional clinical service and a clinical research group. Her research interests covers MS, NMO, CMS and myasthenia gravis and include clinical treatment trials, immunological studies, pathology, biomarkers, genetics and imaging studies on neurodegeneration and its detection and association with inflammation. She has been a UK lead for the National Risk Sharing Scheme which assessed the long-term effectiveness for disease modifying agents in multiple sclerosis, is a board member for the European Charcot Foundation, on the steering committee for MAGNIMS and is the Oxford lead for the European Rare Network for Neuromuscular diseases. She is an elected member of council for the Association of British Neurologists.


Prof. Alexandre Prat
Dr Mara Rocca
Prof. Krzysztof Selmaj
Neurology Center Lodz

Dr. Selmaj is the Professor of Neurology at the Medical University of Lodz (MUL) and a Visiting Associate Professor at Albert Einstein College of Medicine, New York. He is a Chairman at the Department of Neurology and Director of the Neuroimmunology Laboratory at the MUL. Dr. Selmaj received training in neurology and neuroimmunology at the Charing Cross and Westminster Medical School, University of London, and at Albert Einstein College of Medicine, New York. Dr. Selmaj has been elected to serve as a Vice-President of the European Federation of Neurological Societies (EFNS) in 1999-2005 and a member of several other international advisory boards. He wasa President of the Polish Neurological Society. He served as a member of the editorial boards for European Journal of Neurology,Journal of Neuroimmunology, and Polish Neurology and Neurosurgery.His research activity considers investigations in neurobiology and neuroimmunology with a particular interest in mechanisms of demyelination and multiple sclerosis. He published over 150 papers in the field of neurology and immunology.


Prof. Per Soelberg Sorensen
Danish MS Center, Rigshospitalet

Per Soelberg Sorensen is Professor of Neurology at the University of Copenhagen and senior consultant at Department of Neurology, Rigshospitalet, Copenhagen. He is the founder of the Danish Multiple Sclerosis Center. Core elements in his research include development of new MS therapies, translational and biomarker research, and he has initiated and conducted several large international trials. He has authored more than 400 scientific publications, 353 of which are indexed in PubMed. Professor Sorensen was Founding Editor‐in‐chief of the European Journal of Neurology from 1994 to 2003 and is currently member of the editorial board of Multiple Sclerosis Journal, European Journal of Neurology, Therapeutic Advances in Neurological Disorders, and Multiple Sclerosis and Demyelinating Disorders.
Professor Sorensen is Secretary General of the European Committee for Treatment and Research in Multiple sclerosis (ECTRIMS); Executive Board member of the European Academy of Neurology; Executive Board member of the European Charcot Foundation for Research in Multiple Sclerosis; Member of the Medical Advisory Board of the International Federation of Multiple Sclerosis Societies (IFMSS); Member of the International Advisory Committee on Clinical Trials in MS, under the sponsorship of the US National MS Society and ECTRIMS; and Chairman of the Danish Multiple Sclerosis Group.


Prof. Dr. Bernard Uitdehaag
VU University Medical Center, Amsterdam
Prof. Patrick Vermersch
University of Lille